Related Experiment Video
Updated: Jun 3, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Antipsychotic off-label use in the 21st century: An enduring public health concern
1University Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France.
Abstract:
Soon after the introduction of second-generation antipsychotics, antipsychotic off-label use (OLU) progressively became a common prescribing practice. This evolving practice should be regularly monitored considering the growing number of persons exposed to the adverse effects of antipsychotics. The aim of the present review was to synthesise the literature published over the last 15 years on antipsychotic OLU for mental health symptoms. Observational studies confirm the persisting high rate of antipsychotic OLU prescription in two out of three youths and 30-60% of adults using antipsychotics. Increasing rates of low-dose quetiapine prescriptions for anxiety or sleep symptoms are paradigmatic of the current public health concern regarding antipsychotic OLU. Such prescriptions receive impetus from industry-funded marketing strategies and prescribers' feeling of innocuousness, with a resulting underestimation of the risk of adverse drug reactions (ADR). However, antipsychotic OLU should be neither trivialised nor demonised since it may be the only therapeutic option in persons with resistant psychiatric disorders or serious ADR with labelled drugs. To reduce the populational impact of antipsychotic OLU, it is necessary to better control the influence of the pharmaceutical industry regarding newly marketed drugs and to better inform prescribers and users about the risks associated with OLU prescribing.
Insights
Antipsychotic off-label use (OLU) remains high in youth and adults, often for anxiety or sleep. Monitoring OLU is crucial due to potential adverse drug reactions (ADR) and industry influence.
Area of Science:
- Psychiatry
- Pharmacology
- Public Health
Background:
- Off-label use (OLU) of antipsychotics has become common since the introduction of second-generation agents.
- Monitoring antipsychotic OLU is essential due to increasing patient exposure and potential adverse effects.
Purpose of the Study:
- To synthesize literature from the past 15 years on antipsychotic OLU for mental health symptoms.
- To assess the prevalence, drivers, and implications of antipsychotic OLU.
Main Methods:
- Systematic review of observational studies published over the last 15 years.
- Analysis of prescribing patterns and influencing factors for antipsychotic OLU.
Main Results:
- High rates of antipsychotic OLU persist: two out of three youths and 30-60% of adults prescribed antipsychotics use them off-label.
- Low-dose quetiapine for anxiety/sleep exemplifies a public health concern, driven by marketing and perceived low risk.
- Antipsychotic OLU may be necessary for resistant disorders but carries risks of adverse drug reactions (ADR).
Conclusions:
- Antipsychotic OLU is a complex issue requiring careful consideration, balancing potential benefits against risks.
- Reducing the impact of OLU necessitates controlling pharmaceutical industry influence and improving prescriber/patient education on OLU risks.
- Further research and guidelines are needed to optimize antipsychotic prescribing practices.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

